PAIR as percutaneous treatment of hydatid liver cysts

Pelaez, Victor; Kugler, C.; Correa, Daniel; Carpio, Mario Del; Guangiroli, M.; Molina, Juan; Marcos, B; López, Emiliano

doi:10.1016/s0001-706x(00)00058-9

Cited by 61 publications

(31 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Another 40% of cysts will recur in a short time after the cessation of treatment [22,23]. Percutaneous treatment has become very popular over the last two decades due to its lower mortality and morbidity rates [24][25][26][27][28]. Before performing percutaneous treatment, it is very important to know whether there is a relation between the biliary duct and the cyst cavity.…”

Section: Discussionmentioning

confidence: 99%

Endoscopic Management of Biliary Parasitic Diseases

et al. 2009

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Endoscopic Management of Biliary Parasitic Diseases

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Selection must be made by US [14]. Skilled physicians have reported good results [8,101,102]. Despite these results and some progress in medical treatment, surgery is still the treatment of choice for uncomplicated hydatid disease of the liver [48,76,103].…”

Section: Alternative Proceduresmentioning

confidence: 99%

Echinococcus granulosus infection: the challenge of surgical treatment

Buttenschoen

2003

Langenbeck's Archives of Surgery

120

118

View full text Add to dashboard Cite

Cystectomy and omentoplasty for CE should be the standard surgical procedure because it is safe, simple, and effective and meets all criteria of surgical treatment for hydatid disease: entire elimination of the parasite, no intraoperative spillage especially by using a cone, and saving healthy tissue. Pericystectomy should be used for peripherally located liver cysts that are surrounded by parenchyma only partially. Ultrasonic classification of the parasitic lesion should be used as a guideline for therapeutic measures.

show abstract

“…Nevertheless, it is not the optimal therapeutic option for all patients, mainly limited by poor clinical conditions and the location of the hydatid cysts. Thus, other techniques such as PAIR (Puncture, Aspiration, Injection, and Reaspiration) have gained international recognition [13][14][15] ; nevertheless, PAIR has several contraindications, among them the possibility of breakage or fistulation of the cysts. In addition, the location of the cyst in organs such as heart or brain means that PAIR is not always feasible.…”

Section: Introductionmentioning

confidence: 99%

Safety of the Combined Use of Praziquantel and Albendazole in the Treatment of Human Hydatid Disease

Alvela-Suárez

Velasco‐Tirado

Belhassen-García³

et al. 2014

The American Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Abstract. There is still no well-established consensus about the clinical management of hydatidosis. Currently, surgery continues to be the first therapeutic option, although treatment with anti-parasitic drugs is indicated as an adjuvant to surgery to decrease the number of relapses and hydatid cyst size. When surgery is not possible, medical treatment is indicated. Traditionally, albendazole was used in monotherapy as the standard treatment. However, combined therapy with albendazole plus praziquantel appears to improve anti-parasitic effectiveness. To date, no safety studies focusing on such combined therapy have been published for the treatment of hydatidosis. In this work, we analyze the adverse effects seen in 57 patients diagnosed with hydatidosis who were treated with praziquantel plus albendazole combined therapy between 2006 and 2010.

show abstract

PAIR as percutaneous treatment of hydatid liver cysts

Cited by 61 publications

References 16 publications

Endoscopic Management of Biliary Parasitic Diseases

Endoscopic Management of Biliary Parasitic Diseases

Echinococcus granulosus infection: the challenge of surgical treatment

Safety of the Combined Use of Praziquantel and Albendazole in the Treatment of Human Hydatid Disease

Contact Info

Product

Resources

About